The magnitude of functional improvement with intravitreal aflibercept treatment was similar across baseline DRSS risk groups; however, there was a numerical increasing trend in treatment difference compared with laser as baseline DRSS score increased from low to high.
← all excerpts
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies.
1
—
—